Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications
Protein kinases are key mediators of cellular signaling and control cell functions through the phosphorylation of target proteins. They have become major targets for therapeutic agents aimed at treating human diseases, particularly cancer. Protein kinase inhibitors (PKIs) have emerged at the forefro...
Saved in:
| Main Authors: | Salem Baldi, Nanbiao Long, Shu Ma, Li Liu, Abdullah Al-Danakh, Qin Yang, Xinpei Deng, Jindong Xie, Hailin Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0747 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery
by: Rand Shahin, et al.
Published: (2025-12-01) -
Discovery of BBT-176 as a fourth-generation EGFR tyrosine kinase inhibitor
by: Krishna Babu Duggirala, et al.
Published: (2025-07-01) -
Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition Prediction
by: Florian Fischer, et al.
Published: (2025-05-01) -
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery
by: Xiaolei Wu, et al.
Published: (2025-05-01) -
Computational advances in the design and discovery of artemis inhibitors for radiosensitization in cancer therapy
by: Maryam Bashir, et al.
Published: (2025-07-01)